Triflusal ( Triflusal, Disgren, Grendis, Aflen, Triflux )

产品货号. M14050 CAS No. 322-79-2

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

Triflusal
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
产品描述

Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
同义词

Triflusal, Disgren, Grendis, Aflen, Triflux
通路

Angiogenesis
靶点

PDE
受体

PDE; TXA2R
研究领域

Inflammation/Immunology
适应症

——

1.Acta Crystallographica Section A, 49 ( Pt 1), 10-22 (1993)

计算器

产品手册

关联产品

Tofimilast

Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.
Filaminast

Filaminast (WAY-PDA-641;PDA-641;WAY-123641) is a potent and selective PDE4 inhibitor with IC50 of 420 nM, displays 36-fold selectivity over PDE3.
Cilostazol

Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.